Reproduction - Progesterone-mediated oocyte maturation

Click on a target from the pathway image to view related information. Zoom     View Legend

photo_map
 


Progesterone-mediated oocyte maturation

In growing follicles oocytes remain arrested at the I meiotic prophase. For the most vertebrates the maturation process extends up to the II meiotic arrest when the oocytes are ready for fertilization. Failure of the oocyte ovulation results in luteinizing hormone-stimulated progesterone production by follicular cells surrounding the oocyte. Progesterone is considered to be the physiological stimulus for the meiosis resumption [1], [2].

The meiosis reinitiation depends on the activation of maturation-promoting factor (MPF) - the complex consisted of Cell division cycle 2 kinase (CDK1 (p34)) and Cyclin B1 [1]. MPF is maintained in its inactive state by phosphorylation of CDK1 (p34) by Membrane associated tyrosine/threonine 1(Myt1) [3] and WEE1 homolog 2(Wee1B) protein kinases [4]. The MPF is activated through the CDK1 (p34) dephosphorylation by the members of the Cdc25 phosphatase family [5]: Cell division cycle 25 homolog C(Cdc25C) [6], [7] and B (Cdc25B) [8].

Progesterone binds both to the plasma membrane-bound and to the intracellular progesterone receptors. Membrane progesterone receptors belong to the G-protein-coupled receptors PAQR family [9], [10], [11]. In human reproductive tissues Progestin and adipoQ receptor family member VII(PAQR7) and Progestin and adipoQ receptor family member VIII(PAQR8) mediate progesterone induction of oocyte maturation. PAQR7 and PAQR8 directly couple to and activate inhibitory G-protein alpha-i to downregulate Adenylate cyclase activity [12], resulting in intracellular cAMP drop [13], [14] and subsequent inhibition of catalytic activity of protein kinase, cAMP-dependent, catalytic (PKA-cat (cAMP-dependent))[15], [16].

Progesterone-depressed PKA-cat (cAMP-dependent) mediates MPF activation by phosphorylation of CDC25C and Cdc25B phosphatases andWee1B kinase [17], [18], [19].

In oocyte, cytoplasm progesterone binds to the classical progesterone receptor - PR (membrane). Ligand-bound receptor associated with Estrogen receptor 1 (ESR1 membrane) [20], [21] activates v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog(c-Src) via direct interaction, resulting in the activation of Son of sevenless homologs (SOS)/ v-Ha-ras Harvey rat sarcoma viral oncogene homolog (H-RAS)/ v-raf-1 murine leukemia viral oncogene homolog 1 (c-Raf-1) cascade [22], [23].

Glycogen synthase kinase-3b (GSK3 beta) is a kinase that phosphorylates and inactivates Aurora kinase A (Aurora-A) [24]. Upon progesterone influence, GSK3 beta is inhibited by phosphorylation on Ser9 [25], known to be a target for the Ribosomal protein S6 kinase, 90kDa protein kinase (p90Rsk) [26], [27].

De novo protein synthesis is essential for meiotic progression to metaphase II. Depressed GSK3 beta leads thereby to the Aurora-A activation, the following phosphorylation of the Cytoplasmic polyadenylation element binding protein 1 (CPEB1) [24], [28], enhanced cytoplasmic mRNA polyadenylation and increased translation of molecules required for oocyte maturation [29], such as v-mos Moloney murine sarcoma viral oncogene homolog (c-Mos) or Speedy homolog A (SPDY1) [29].

In response to progesterone, newly synthesized SPDY1 binds to and activates free monomeric CDK1 (p34), resulting in CDK1 (p34) resistance to inhibitory phosphorylations by Wee1B and Myt1 kinases[30], [31].

In vertebrates progesterone induces MAP kinases activation - the downstream cascade of Mitogen-activated protein kinase kinase 1 (MEK1), Mitogen-activated protein kinase 1(ERK2) and p90Rsk [32]. MAPK cascade is stimulated both through c-Src [22], [23] and by the translational up-regulation of c-Mos [29]. Afterwards ERK2 activates Wee1B [33] and CDC25C [34], and p90Rsk1 inhibits Myt1, thus regulating the CDK1 phosphorylation status and subsequent MPF activation [35].

The Polo-like kinase 1(PLK1) is also a trigger activating MPF in response to progesterone: PLK1 activates Myt1 kinase and inhibits Cdc25C, thereby favoring the formation of CDK1 activity and the initiation of the autoamplification loop [36], as the PLK1 activity is under the control of CDK1 itself [37].

Activated p90Rsk phosphorylates and activates Budding uninhibited by Benzimidazoles 1 homolog (BUB1), leading to the inhibition of Cell division cycle 20 homolog (CDC20), the member of the Anaphase promoting complex (APC), and thus resulting in the metaphase/anaphase transition blockage [32], [38].



References

  1. Schmitt A, Nebreda AR
    Signalling pathways in oocyte meiotic maturation. Journal of cell science 2002 Jun 15;115(Pt 12):2457-9
  2. van den Hurk R, Zhao J
    Formation of mammalian oocytes and their growth, differentiation and maturation within ovarian follicles. Theriogenology 2005 Apr 1;63(6):1717-51
  3. Wells NJ, Watanabe N, Tokusumi T, Jiang W, Verdecia MA, Hunter T
    The C-terminal domain of the Cdc2 inhibitory kinase Myt1 interacts with Cdc2 complexes and is required for inhibition of G(2)/M progression. Journal of cell science 1999 Oct;112 ( Pt 19):3361-71
  4. Nakanishi M, Ando H, Watanabe N, Kitamura K, Ito K, Okayama H, Miyamoto T, Agui T, Sasaki M
    Identification and characterization of human Wee1B, a new member of the Wee1 family of Cdk-inhibitory kinases. Genes to cells : devoted to molecular & cellular mechanisms 2000 Oct;5(10):839-47
  5. Nilsson I, Hoffmann I
    Cell cycle regulation by the Cdc25 phosphatase family. Progress in cell cycle research 2000;4:107-14
  6. Borgne A, Meijer L
    Sequential dephosphorylation of p34(cdc2) on Thr-14 and Tyr-15 at the prophase/metaphase transition. The Journal of biological chemistry 1996 Nov 1;271(44):27847-54
  7. Gautier J, Solomon MJ, Booher RN, Bazan JF, Kirschner MW
    cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell 1991 Oct 4;67(1):197-211
  8. Lincoln AJ, Wickramasinghe D, Stein P, Schultz RM, Palko ME, De Miguel MP, Tessarollo L, Donovan PJ
    Cdc25b phosphatase is required for resumption of meiosis during oocyte maturation. Nature genetics 2002 Apr;30(4):446-9
  9. Zhu Y, Rice CD, Pang Y, Pace M, Thomas P
    Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proceedings of the National Academy of Sciences of the United States of America 2003 Mar 4;100(5):2231-6
  10. Tang YT, Hu T, Arterburn M, Boyle B, Bright JM, Emtage PC, Funk WD
    PAQR proteins: a novel membrane receptor family defined by an ancient 7-transmembrane pass motif. Journal of molecular evolution 2005 Sep;61(3):372-80
  11. Smith JL, Kupchak BR, Garitaonandia I, Hoang LK, Maina AS, Regalla LM, Lyons TJ
    Heterologous expression of human mPRalpha, mPRbeta and mPRgamma in yeast confirms their ability to function as membrane progesterone receptors. Steroids 2008 Oct;73(11):1160-73
  12. Thomas P, Pang Y, Dong J, Groenen P, Kelder J, de Vlieg J, Zhu Y, Tubbs C
    Steroid and G protein binding characteristics of the seatrout and human progestin membrane receptor alpha subtypes and their evolutionary origins. Endocrinology 2007 Feb;148(2):705-18
  13. Simonds WF
    G protein regulation of adenylate cyclase. Trends in pharmacological sciences 1999 Feb;20(2):66-73
  14. Sheng Y, Tiberi M, Booth RA, Ma C, Liu XJ
    Regulation of Xenopus oocyte meiosis arrest by G protein betagamma subunits. Current biology : CB 2001 Mar 20;11(6):405-16
  15. Conti M, Andersen CB, Richard F, Mehats C, Chun SY, Horner K, Jin C, Tsafriri A
    Role of cyclic nucleotide signaling in oocyte maturation. Molecular and cellular endocrinology 2002 Feb 22;187(1-2):153-9
  16. Wang J, Liu XJ
    Progesterone inhibits protein kinase A (PKA) in Xenopus oocytes: demonstration of endogenous PKA activities using an expressed substrate. Journal of cell science 2004 Oct 1;117(Pt 21):5107-16
  17. Shibuya EK
    G2 cell cycle arrest--a direct link between PKA and Cdc25C. Cell cycle (Georgetown, Tex.) 2003 Jan-Feb;2(1):39-41
  18. Han SJ, Chen R, Paronetto MP, Conti M
    Wee1B is an oocyte-specific kinase involved in the control of meiotic arrest in the mouse. Current biology : CB 2005 Sep 20;15(18):1670-6
  19. Han SJ, Conti M
    New pathways from PKA to the Cdc2/cyclin B complex in oocytes: Wee1B as a potential PKA substrate. Cell cycle (Georgetown, Tex.) 2006 Feb;5(3):227-31
  20. Migliaccio A, Piccolo D, Castoria G, Di Domenico M, Bilancio A, Lombardi M, Gong W, Beato M, Auricchio F
    Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. The EMBO journal 1998 Apr 1;17(7):2008-18
  21. Ballaré C, Uhrig M, Bechtold T, Sancho E, Di Domenico M, Migliaccio A, Auricchio F, Beato M
    Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells. Molecular and cellular biology 2003 Mar;23(6):1994-2008
  22. Boonyaratanakornkit V, Scott MP, Ribon V, Sherman L, Anderson SM, Maller JL, Miller WT, Edwards DP
    Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Molecular cell 2001 Aug;8(2):269-80
  23. Tokmakov A, Iwasaki T, Itakura S, Sato K, Shirouzu M, Fukami Y, Yokoyama S
    Regulation of Src kinase activity during Xenopus oocyte maturation. Developmental biology 2005 Feb 15;278(2):289-300
  24. Sarkissian M, Mendez R, Richter JD
    Progesterone and insulin stimulation of CPEB-dependent polyadenylation is regulated by Aurora A and glycogen synthase kinase-3. Genes & development 2004 Jan 1;18(1):48-61
  25. Justman QA, Serber Z, Ferrell JE Jr, El-Samad H, Shokat KM
    Tuning the activation threshold of a kinase network by nested feedback loops. Science (New York, N.Y.) 2009 Apr 24;324(5926):509-12
  26. Eldar-Finkelman H
    Glycogen synthase kinase 3: an emerging therapeutic target. Trends in molecular medicine 2002 Mar;8(3):126-32
  27. Ding Q, Xia W, Liu JC, Yang JY, Lee DF, Xia J, Bartholomeusz G, Li Y, Pan Y, Li Z, Bargou RC, Qin J, Lai CC, Tsai FJ, Tsai CH, Hung MC
    Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Molecular cell 2005 Jul 22;19(2):159-70
  28. Mendez R, Hake LE, Andresson T, Littlepage LE, Ruderman JV, Richter JD
    Phosphorylation of CPE binding factor by Eg2 regulates translation of c-mos mRNA. Nature 2000 Mar 16;404(6775):302-7
  29. Kishimoto T
    Cell-cycle control during meiotic maturation. Current opinion in cell biology 2003 Dec;15(6):654-63
  30. Ferby I, Blazquez M, Palmer A, Eritja R, Nebreda AR
    A novel p34(cdc2)-binding and activating protein that is necessary and sufficient to trigger G(2)/M progression in Xenopus oocytes. Genes & development 1999 Aug 15;13(16):2177-89
  31. Karaiskou A, Perez LH, Ferby I, Ozon R, Jessus C, Nebreda AR
    Differential regulation of Cdc2 and Cdk2 by RINGO and cyclins. The Journal of biological chemistry 2001 Sep 21;276(38):36028-34
  32. Maller JL, Schwab MS, Gross SD, Taieb FE, Roberts BT, Tunquist BJ
    The mechanism of CSF arrest in vertebrate oocytes. Molecular and cellular endocrinology 2002 Feb 22;187(1-2):173-8
  33. Walter SA, Guadagno SN, Ferrell JE Jr
    Activation of Wee1 by p42 MAPK in vitro and in cycling xenopus egg extracts. Molecular biology of the cell 2000 Mar;11(3):887-96
  34. Wang R, He G, Nelman-Gonzalez M, Ashorn CL, Gallick GE, Stukenberg PT, Kirschner MW, Kuang J
    Regulation of Cdc25C by ERK-MAP kinases during the G2/M transition. Cell 2007 Mar 23;128(6):1119-32
  35. Palmer A, Gavin AC, Nebreda AR
    A link between MAP kinase and p34(cdc2)/cyclin B during oocyte maturation: p90(rsk) phosphorylates and inactivates the p34(cdc2) inhibitory kinase Myt1. The EMBO journal 1998 Sep 1;17(17):5037-47
  36. Perdiguero E, Nebreda AR
    Regulation of Cdc25C activity during the meiotic G2/M transition. Cell cycle (Georgetown, Tex.) 2004 Jun;3(6):733-7
  37. Abrieu A, Brassac T, Galas S, Fisher D, Labbé JC, Dorée M
    The Polo-like kinase Plx1 is a component of the MPF amplification loop at the G2/M-phase transition of the cell cycle in Xenopus eggs. Journal of cell science 1998 Jun;111 ( Pt 12):1751-7
  38. Schwab MS, Roberts BT, Gross SD, Tunquist BJ, Taieb FE, Lewellyn AL, Maller JL
    Bub1 is activated by the protein kinase p90(Rsk) during Xenopus oocyte maturation. Current biology : CB 2001 Feb 6;11(3):141-50

Target Details

Click on a target from the pathway image to view related information.